Global Down Syndrome

Issue 3 of 4 2017

Issue link: https://viewer.e-digitaledition.com/i/866792

Contents of this Issue

Navigation

Page 8 of 31

Exploring the Roots of Lung Disease in Down Syndrome CONDITIONS SUCH AS underdeveloped lungs, known as pulmonary hypoplasia, and high blood pressure in the arteries of the lungs, known as pulmonary arterial hypertension (PAH), occur in approximately 20 percent of children born with Down syndrome, according to data collected by Csaba Galambos, M.D., Ph.D., a pediatric pathologist in the Children's Hospital Colorado Department of Pathology and Laboratory Medicine and Associate Professor of Pathology at the University of Colorado School of Medicine. A group of researchers led by Dr. Galambos is exploring, for the first time, why individuals with Down syndrome are more susceptible to these conditions. His lab has hypothesized that central to the development of pulmonary hypoplasia and PAH is the suppression of the process that prompts the growth of new blood vessels, a chain of events called angiogenesis. Their discoveries could lead not only to therapies for pulmonary disease in individuals with Down syndrome, but also to treatments that may improve lung development and function in all patients. A DOUBLE-EDGED SWORD Dr. Galambos' fascination with angiogenesis began years ago, when COULD FACTORS THAT PREVENT THE FORMATION OF NEW BLOOD VESSELS IN THE LUNGS ACCOUNT FOR THE HIGH PREVALENCE OF PULMONARY DISEASE IN INFANTS WITH DOWN SYNDROME? THE ANSWER COULD HAVE FAR-REACHING IMPLICATIONS THAT EXTEND BEYOND LUNG HEALTH. GLOBALDOWNSYNDROME.ORG 9

Articles in this issue

Links on this page

Archives of this issue

view archives of Global Down Syndrome - Issue 3 of 4 2017